Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells

Mario Menk*, Jan Adriaan Graw, Clarissa von Haefen, Marco Sifringer, David Schwaiberger, Thomas Unger, Ulrike Steckelings, Claudia D. Spies

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Recently, AT2 receptors have been discovered on the surface of human immunocompetent cells such as monocytes. Data on regulative properties of this receptor on the cellular immune response are poor. We hypothesized that direct stimulation of the AT2 receptor mediates anti-inflammatory responses in these cells. Human monocytic THP-1 and U937 cells were stimulated with lipopolysaccharide (LPS) and the selective AT2 receptor agonist Compound 21 (C21). Expression of pro- and anti-inflammatory cytokines IL-6, IL-10, tumor necrosis factor-alpha (TNF alpha), and IL-1 beta were analyzed on both the transcriptional and the translational level over course of time. Treatment with C21 attenuated the expression of TNF alpha, IL-6, and IL-10 after LPS challenge in both cell lines in a time- and dose-dependent manner. We conclude that selective AT2 receptor stimulation acts anti-inflammatory in human monocytes. Modulation of cytokine response by AT2 receptor activation might be a beneficial and novel treatment concept in inflammatory conditions.
Original languageEnglish
Pages (from-to)1690-1699
Issue number4
Publication statusPublished - Aug 2015


  • AT2 receptor
  • Compound 21 (C21)
  • THP-1 cells
  • inflammation
  • monocytes

Cite this